ArticleCell cycle (Georgetown, Tex.)2019

PIR promotes tumorigenesis of breast cancer by upregulating cell cycle activator E2F1.

Muhammad Suleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.